Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106911 · ClinicalTrials.gov registry record · NA
Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 1,080
- Enrollment target
NCT01106911 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,080 participants.
The verdict
NCT01106911, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,080 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate that digital breast tomosynthesis (DBT) in combination with full field digital mammography (FFDM) has the potential to reduce significantly baseline screening recall rates without a loss in the detection of cancers. The primary hypothesis of the study is that DBT in combination with FFDM will reduce baseline screening mammography recall rates in negative examinations by at least 20%.
Interventions
- DEVICE tomosynthesis and screening mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,080 participants |
| Start Date | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01106911
The ClinicalTrials.gov registry entry for NCT01106911 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,080 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tomosynthesis and screening mammography is the first listed.
NCT01106911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01106911 about?
NCT01106911 is a clinical study titled "Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment". The objective of this study is to demonstrate that digital breast tomosynthesis (DBT) in combination with full field digital mammography (FFDM) has the potential to reduce significantly baseline screening recall rates without a loss in the detection of cancers. The primary hypothesis of the study is...
What is the current status of trial NCT01106911?
This trial is currently completed. It is a NA study. The enrollment target is 1,080 participants. The study started on 2010-05.
What interventions are being tested in trial NCT01106911?
The interventions under investigation include: tomosynthesis and screening mammography (DEVICE).
Who is sponsoring clinical trial NCT01106911?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.